<?xml version="1.0" encoding="UTF-8"?>
<EXPERIMENT_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <EXPERIMENT accession="SRX18518308" alias="CORVASEQ-CLT-004951_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518308</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004951_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987344">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987344</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004951_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004951</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518309" alias="CORVASEQ-CLT-004952_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518309</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004952_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987345">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987345</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004952_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004952</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518310" alias="CORVASEQ-CLT-004953_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518310</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004953_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987346">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987346</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004953_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004953</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518311" alias="CORVASEQ-CLT-004954_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518311</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004954_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987347">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987347</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004954_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004954</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518312" alias="CORVASEQ-CLT-004955_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518312</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004955_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987348">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987348</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004955_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004955</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518313" alias="CORVASEQ-CLT-004956_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518313</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004956_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987349">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987349</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004956_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004956</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518314" alias="CORVASEQ-CLT-004957_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518314</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004957_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987350">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987350</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004957_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004957</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518315" alias="CORVASEQ-CLT-004958_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518315</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004958_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987351">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987351</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004958_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004958</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518316" alias="CORVASEQ-CLT-004959_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518316</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004959_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987352">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987352</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004959_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004959</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518317" alias="CORVASEQ-CLT-004960_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518317</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004960_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987353">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987353</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004960_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004960</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518318" alias="CORVASEQ-CLT-004961_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518318</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004961_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987354">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987354</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004961_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004961</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518319" alias="CORVASEQ-CLT-004962_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518319</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004962_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987355">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987355</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004962_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004962</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518320" alias="CORVASEQ-CLT-004963_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518320</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004963_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987356">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987356</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004963_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004963</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518321" alias="CORVASEQ-CLT-004964_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518321</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004964_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987357">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987357</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004964_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004964</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518322" alias="CORVASEQ-CLT-004965_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518322</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004965_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987358">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987358</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004965_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004965</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518323" alias="CORVASEQ-CLT-004966_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518323</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004966_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987359">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987359</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004966_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004966</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518324" alias="CORVASEQ-CLT-004967_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518324</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004967_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987360">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987360</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004967_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004967</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518325" alias="CORVASEQ-CLT-004968_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518325</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004968_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987361">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987361</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004968_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004968</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518326" alias="CORVASEQ-CLT-004969_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518326</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004969_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987362">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987362</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004969_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004969</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518327" alias="CORVASEQ-CLT-004970_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518327</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004970_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987363">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987363</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004970_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004970</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518328" alias="CORVASEQ-CLT-004971_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518328</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004971_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987364">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987364</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004971_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004971</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518329" alias="CORVASEQ-CLT-004972_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518329</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004972_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987365">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987365</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004972_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004972</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518330" alias="CORVASEQ-CLT-004973_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518330</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004973_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987366">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987366</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004973_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004973</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518331" alias="CORVASEQ-CLT-004974_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518331</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004974_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987367">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987367</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004974_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004974</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518332" alias="CORVASEQ-CLT-004975_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518332</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004975_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987368">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987368</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004975_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004975</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518333" alias="CORVASEQ-CLT-004976_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518333</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004976_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987369">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987369</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004976_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004976</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518334" alias="CORVASEQ-CLT-004977_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518334</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004977_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987370">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987370</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004977_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004977</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518335" alias="CORVASEQ-CLT-004978_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518335</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004978_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987371">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987371</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004978_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004978</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518336" alias="CORVASEQ-CLT-004979_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518336</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004979_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987372">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987372</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004979_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004979</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518337" alias="CORVASEQ-CLT-004980_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518337</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004980_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987373">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987373</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004980_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004980</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518338" alias="CORVASEQ-CLT-004981_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518338</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004981_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987374">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987374</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004981_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004981</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518339" alias="CORVASEQ-CLT-004982_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518339</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004982_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987375">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987375</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004982_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004982</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518340" alias="CORVASEQ-CLT-004983_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518340</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004983_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987376">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987376</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004983_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004983</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518341" alias="CORVASEQ-CLT-004984_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518341</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004984_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987377">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987377</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004984_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004984</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518342" alias="CORVASEQ-CLT-004986_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518342</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004986_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987378">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987378</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004986_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004986</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518343" alias="CORVASEQ-CLT-004987_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518343</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004987_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987379">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987379</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004987_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004987</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518344" alias="CORVASEQ-CLT-004988_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518344</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004988_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987380">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987380</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004988_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004988</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518345" alias="CORVASEQ-CLT-004989_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518345</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004989_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987381">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987381</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004989_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004989</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518346" alias="CORVASEQ-CLT-004990_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518346</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004990_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987382">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987382</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004990_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004990</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518347" alias="CORVASEQ-CLT-004991_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518347</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004991_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987383">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987383</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004991_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004991</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518348" alias="CORVASEQ-CLT-005012_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518348</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005012_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987384">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987384</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005012_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005012</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518349" alias="CORVASEQ-CLT-005013_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518349</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005013_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987385">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987385</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005013_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005013</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518350" alias="CORVASEQ-CLT-005014_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518350</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005014_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987386">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987386</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005014_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005014</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518351" alias="CORVASEQ-CLT-005015_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518351</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005015_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987387">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987387</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005015_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005015</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518352" alias="CORVASEQ-CLT-005016_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518352</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005016_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987388">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987388</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005016_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005016</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518353" alias="CORVASEQ-CLT-005017_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518353</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005017_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987389">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987389</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005017_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005017</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518354" alias="CORVASEQ-CLT-005018_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518354</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005018_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987390">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987390</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005018_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005018</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518355" alias="CORVASEQ-CLT-005019_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518355</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005019_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987391">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987391</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005019_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005019</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518356" alias="CORVASEQ-CLT-005020_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518356</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005020_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987392">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987392</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005020_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005020</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518357" alias="CORVASEQ-CLT-005021_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518357</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005021_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987393">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987393</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005021_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005021</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518358" alias="CORVASEQ-CLT-005023_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518358</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005023_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987394">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987394</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005023_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005023</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518359" alias="CORVASEQ-CLT-005024_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518359</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005024_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987395">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987395</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005024_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005024</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518360" alias="CORVASEQ-CLT-005025_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518360</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005025_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987396">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987396</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005025_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005025</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518361" alias="CORVASEQ-CLT-005026_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518361</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005026_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987397">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987397</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005026_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005026</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518362" alias="CORVASEQ-CLT-005027_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518362</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005027_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987398">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987398</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005027_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005027</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518363" alias="CORVASEQ-CLT-005028_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518363</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005028_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987399">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987399</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005028_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005028</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518364" alias="CORVASEQ-CLT-005029_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518364</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005029_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987400">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987400</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005029_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005029</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518365" alias="CORVASEQ-CLT-005030_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518365</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005030_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987401">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987401</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005030_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005030</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518366" alias="CORVASEQ-CLT-005031_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518366</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005031_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987402">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987402</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005031_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005031</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518367" alias="CORVASEQ-CLT-005032_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518367</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005032_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987403">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987403</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005032_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005032</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518368" alias="CORVASEQ-CLT-005033_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518368</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005033_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987404">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987404</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005033_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005033</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518369" alias="CORVASEQ-CLT-005034_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518369</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005034_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987405">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987405</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005034_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005034</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518370" alias="CORVASEQ-CLT-005035_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518370</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005035_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987406">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987406</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005035_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005035</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518371" alias="CORVASEQ-CLT-005037_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518371</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005037_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987407">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987407</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005037_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005037</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518372" alias="CORVASEQ-CLT-005038_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518372</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005038_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987408">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987408</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005038_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005038</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518373" alias="CORVASEQ-CLT-005039_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518373</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005039_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987409">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987409</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005039_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005039</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518374" alias="CORVASEQ-CLT-005040_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518374</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005040_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987410">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987410</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005040_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005040</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518375" alias="CORVASEQ-CLT-005041_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518375</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005041_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987411">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987411</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005041_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005041</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518376" alias="CORVASEQ-CLT-005042_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518376</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005042_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987412">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987412</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005042_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005042</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518377" alias="CORVASEQ-CLT-005043_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518377</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005043_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987413">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987413</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005043_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005043</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518378" alias="CORVASEQ-CLT-004992_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518378</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004992_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987414">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987414</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004992_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004992</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518379" alias="CORVASEQ-CLT-004993_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518379</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004993_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987415">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987415</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004993_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004993</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518380" alias="CORVASEQ-CLT-004994_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518380</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004994_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987416">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987416</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004994_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004994</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518381" alias="CORVASEQ-CLT-004995_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518381</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004995_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987417">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987417</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004995_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004995</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518382" alias="CORVASEQ-CLT-004996_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518382</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004996_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987418">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987418</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004996_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004996</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518383" alias="CORVASEQ-CLT-004997_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518383</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004997_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987419">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987419</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004997_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004997</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518384" alias="CORVASEQ-CLT-004998_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518384</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004998_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987420">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987420</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004998_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004998</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518385" alias="CORVASEQ-CLT-004999_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518385</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004999_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987421">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987421</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-004999_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-004999</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518386" alias="CORVASEQ-CLT-005000_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518386</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005000_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987422">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987422</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005000_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005000</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518387" alias="CORVASEQ-CLT-005001_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518387</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005001_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987423">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987423</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005001_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005001</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518388" alias="CORVASEQ-CLT-005002_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518388</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005002_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987424">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987424</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005002_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005002</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518389" alias="CORVASEQ-CLT-005003_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518389</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005003_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987425">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987425</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005003_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005003</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518390" alias="CORVASEQ-CLT-005004_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518390</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005004_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987426">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987426</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005004_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005004</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518391" alias="CORVASEQ-CLT-005005_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518391</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005005_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987427">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987427</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005005_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005005</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518392" alias="CORVASEQ-CLT-005006_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518392</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005006_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987428">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987428</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005006_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005006</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518393" alias="CORVASEQ-CLT-005007_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518393</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005007_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987429">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987429</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005007_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005007</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518394" alias="CORVASEQ-CLT-005008_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518394</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005008_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987430">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987430</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005008_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005008</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518395" alias="CORVASEQ-CLT-005009_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518395</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005009_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987431">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987431</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005009_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005009</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518396" alias="CORVASEQ-CLT-005010_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518396</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005010_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987432">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987432</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005010_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005010</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18518397" alias="CORVASEQ-CLT-005011_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18518397</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005011_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss1a primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15987433">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15987433</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-005011_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-005011</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
</EXPERIMENT_SET>
